METHOD FOR TREATMENT OF SYRINGOMYELIA

FIELD: medicine, neurology. ^ SUBSTANCE: method involves carrying out CMT-phoresis by paravertebral route at the level of damaged segments by course for 10-15 every day procedures with administration of alflutop. Alflutop is administrated from cathode in the continuous regimen PII for 5 min for each...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIRSAEV TAGIR RAFAILOVICH, BORISOVA NINEL' ANDREEVNA, VASIL'EVA ELENA ALEKSANDROVNA, BASHKATOV SERGEJ ALEKSANDROVICH, TUNIK VALERIJ FEDOROVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	ELECTROTHERAPY HUMAN NECESSITIES HYGIENE MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, neurology. ^ SUBSTANCE: method involves carrying out CMT-phoresis by paravertebral route at the level of damaged segments by course for 10-15 every day procedures with administration of alflutop. Alflutop is administrated from cathode in the continuous regimen PII for 5 min for each PP III and IV and with the modulation frequency 70 Hz, the modulation deepness 50%, strength of current 8-12 mA with the expressed vibration. Method provides decreasing the expression of neurological deficiency, cavity sizes in spinal cord by MPT data and carrying out the correction of serum blood biochemical indices. Invention can be used in treatment of syringomyelia. ^ EFFECT: improved method of treatment. ^ 2 cl, 2 ex